Status:
COMPLETED
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Adenocarcinoma of Ovary
Adenocarcinoma, Tubular
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this prospective, multi-centre, exploratory research project is the establishment of a platform for in-depth tumour profiling in patients with advanced and metastatic High-Grade Adenocarcin...
Detailed Description
TUPRO-Gyn is part of the Tumour Profiler (TUPRO) research collaboration, which aims to help generate information about patients' individual tumour biology for patients with advanced malignancies, usin...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Eastern Cooperative Oncology Group performance status score ≤ 2 (not bedridden for more than 50% of waking hours)
- Primary or recurrent HGAC of ovarian, tubal or peritoneal origin International Federation of Gynecology and Obstetrics (FIGO) stage III or IV
- Written informed consent according to national legal and regulatory requirements prior to any project specific procedures
Exclusion
- Any other serious underlying medical, psychiatric, psychological, familial or geographical condition, which in the judgment of the project leader may interfere with the project or affect patient compliance
- Legal incompetence
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06599749
Start Date
December 1 2018
End Date
September 30 2021
Last Update
September 19 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031
2
Kantonsspital Baselland
Liestal, Switzerland, 4410
3
University Hospital Zurich
Zurich, Switzerland, 8091